Aggregometry and thromboelastography to identify the timing to trach a COVID‐19 patient receiving both antiplatelet therapy and enoxaparin

In COVID‐19 patients receiving enoxaparin and antiplatelets therapy, aggregometry and thromboelastography might be considered an adjunctive tool to identify the time to perform procedures at risk of bleeding, such as tracheostomy.

Detalles Bibliográficos
Autores principales: Tescione, Marco, Vadalà, Eugenio, Marano, Graziella, Bruni, Andrea, Garofalo, Eugenio, Lavalle, Ovidia, Longhini, Federico, Battaglia, Enzo, Polimeni, Nicola, Labate, Demetrio, Caracciolo, Sarah, Giordano, Francesco, Caracciolo, Massimo, Macheda, Sebastiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981626/
https://www.ncbi.nlm.nih.gov/pubmed/33768781
http://dx.doi.org/10.1002/ccr3.3442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981626/
https://www.ncbi.nlm.nih.gov/pubmed/33768781
http://dx.doi.org/10.1002/ccr3.3442

Ejemplares similares